How well does a flu vaccine work? DRIVE project evaluates performance
Despite challenging conditions posed by the COVID-19 outbreak, the DRIVE project successfully tested how well various brands of flu vaccines worked across five European countries and a range of age groups.
News
Policy & Recommendations
Data-informed decision-making: Driving life-course immunisation in National Immunisations Programs (NIPs)
CLCI, together with MEP Tomislav Sokol and the European Institute for Innovation through Health Data, has produced a report exploring ways of improving the use of data in national immunisation programme planning.
News
Article
Scientific Papers
Real-World Effectiveness of BNT162b2 Against Infection and Severe Diseases in Children and Adolescents
The efficacy of the BNT162b2 vaccine in pediatrics was assessed by randomised trials before the Omicron variant’s emergence.
Simvastatin in Critically Ill Patients with Covid-19
The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.
Public health action needed to mitigate the impact of respiratory pathogens for 2023-24 winter season in Europe
In an epidemiological update, the ECDC urges EU/EEA Member States to strengthen vaccination campaigns and prepare for the possible need to increase emergency department and ICU capacity
Evaluation of the effectiveness and impact of Nirsevimab in Galicia
The NIRSE-GAL study shows in real time the evolution of the coverage achieved by immunisation with Nirsevimab in children and compares RSV admissions in different population groups of children and adults in Galicia in Spain with previous years.
News
Policy & Recommendations
Study on the coherence, complementarity, and continued relevance of actions in the Council Recommendation on strengthened cooperation against vaccine-preventable diseases
Since 2018, the work of the European Commission on vaccination has been guided by the Council Recommendation on strengthened cooperation against vaccine-preventable diseases. The aim of this report is to support possible policy developments in the future.
An unconventional vaccination strategy against influenza viruses from humans and swine
Influenza is not a single virus, but a collection of subtypes broken down into many different strains.
First results in using new tools to tackle respiratory syncytial virus
Protecting infants from RSV with new tools: vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent RSV among young children. Are those tools working?
World Diabetes Day 2023: Why Influenza and Diabetes are important to consider jointly?
With the support of Sanofi, the Influenza Diabetes Community conducted a communications campaign to raise awareness of the impact of influenza on diabetes patients.
Hyperglycemia and glucose variability are associated with worse survival in mechanically ventilated COVID-19 patients: the prospective Maastricht Intensive Care Covid Cohort
Among 232 mechanically ventilated COVID-19 patients, 21.1% had known diabetes mellitus, whereas 16.9% in wave 2 had unknown diabetes mellitus.
News
Policy & Recommendations
Flash Report: Third meeting of the Public Health Expert Group (PHEG)
Chaired by DG SANTE, EU Member States agreed on prioritising for 2024-2026: health promotion & prevention of non-communicable diseases; healthy longevity/lifelong prevention; vaccine-preventable diseases & vaccination; and long COVID, amongst others.